News & Insights

Subscribe

  • People
  • Offices
    • back
    • Offices
    • North America
      • back
      • North America
      • Atlanta
      • Austin
      • Charlotte
      • Chicago
      • Dallas
      • Denver
      • Houston
      • Los Angeles
      • Miami
      • New York
      • Northern Virginia
      • San Francisco
      • Silicon Valley
      • Washington, D.C.
    • Europe & Middle East
      • back
      • Europe & Middle East
      • Abu Dhabi
      • Brussels
      • Dubai
      • Frankfurt
      • Geneva
      • London
      • Paris
      • Riyadh
    • Asia
      • back
      • Asia
      • Singapore
      • Tokyo
  • Capabilities
    • back
    • Capabilities
    • Corporate, Finance and Investments
      • back
      • Corporate, Finance and Investments
      • Overview
      • Activist Defense
      • Capital Markets
      • Construction and Procurement
      • Corporate Governance
      • Emerging Companies and Venture Capital
      • Employee Benefits and Executive Compensation
      • Energy and Infrastructure Projects
      • Financial Restructuring
      • Fund Finance
      • Global Human Capital and Compliance
      • Investment Funds and Asset Management
      • Leveraged Finance
      • Mergers and Acquisitions (M&A)
      • Middle East and Islamic Finance and Investment
      • Private Credit & Special Situations
      • Private Equity
      • Public Companies
      • Real Estate
      • Structured Finance and Securitization
      • Tax
      • Technology Transactions
    • Government Matters
      • back
      • Government Matters
      • Overview
      • Antitrust
      • Data, Privacy and Security
      • Environmental, Health and Safety
      • FDA and Life Sciences
      • Government Advocacy and Public Policy
      • Government Contracts
      • Healthcare
      • Innovation Protection
      • International Trade
      • National Security and Corporate Espionage
      • Securities Enforcement and Regulation
      • Special Matters and Government Investigations
    • Trial and Global Disputes
      • back
      • Trial and Global Disputes
      • Overview
      • Antitrust
      • Appellate, Constitutional and Administrative Law
      • Bankruptcy and Insolvency Litigation
      • Class Action Defense
      • Commercial Litigation
      • Construction and Engineering Disputes
      • Corporate and Securities Litigation
      • E-Discovery
      • Innovation Protection
      • Intellectual Property
      • International Arbitration and Litigation
      • Labor and Employment
      • Product Liability
      • Professional Liability
      • Toxic & Environmental Torts
    • Industries / Issues
      • back
      • Industries / Issues
      • Industries
      • Automotive, Transportation and Mobility
      • Energy Transition
      • Energy
      • Financial Services
      • Food and Beverage
      • Higher Education
      • Life Sciences and Healthcare
      • Technology
      • Issues
      • Artificial Intelligence (AI) and Machine Learning
      • Buy American
      • Crisis Management
      • Doing Business in Latin America
      • Environmental Agenda
      • Environmental, Social and Governance (ESG)
      • Focus on Women's Health
      • Russia/Ukraine
      • Special Purpose Acquisition Companies (SPACs)
  • Careers
    • back
    • Careers
    • Lawyers
      • back
      • Lawyers
      • Experienced Lawyers
    • Students
      • back
      • Students
      • Law Students
      • UK Graduate Recruitment
    • Judicial Clerks
      • back
      • Judicial Clerks
      • Judicial Clerks
    • Business Professionals
      • back
      • Business Professionals
      • Business Professionals
  • News & Insights
    • back
    • News & Insights
    • News
      • back
      • News
      • All News
      • Cases & Deals
      • In the News
      • Press Releases
      • Recognitions
    • Events
      • back
      • Events
      • All Events
      • Conferences
      • Speaking Engagements
      • Webinars
    • Insights
      • back
      • Insights
      • All Insights
      • Newsletters
      • Client Alerts
      • Thought Leadership
      • Articles
      • Feature
      • BLOGS
      • Auditor Liability Bulletin
      • ESG Excellence
  • About
    • back
    • About
    • Our Firm
      • back
      • Our Firm
      • History
      • Our Values
    • Our Culture
      • back
      • Our Culture
      • Overview
    • Citizenship
      • back
      • Citizenship
      • Overview
      • Pro Bono
      • Community Focus
  • Languages

News & Insights

  • News
    • back
    • News
    • All News
    • Cases & Deals
    • In the News
    • Press Releases
    • Recognitions
  • Events
    • back
    • Events
    • All Events
    • Conferences
    • Speaking Engagements
    • Webinars
  • Insights
    • back
    • Insights
    • All Insights
    • Newsletters
    • Client Alerts
    • Thought Leadership
    • Articles
    • Feature
    • BLOGS
    • Auditor Liability Bulletin
    • ESG Excellence

Insights 11 results

Article · Source: American Bankruptcy Institute

April 3, 2025
A Tale of Two Cases: Navigating Conflicts of Interest in Bankruptcy Cases

Client Alert

February 20, 2025
Despite Reduced Investigative Authority, Congressional Democrats Ramp Up Trump Administration Oversight

Client Alert

October 9, 2023
Generative AI: Investigations Watch

Newsletter

September 20, 2023
Financial Service Focus - September 2023

Client Alert

March 13, 2023
DOJ Corporate Enforcement Policy Revisions Target Executive Compensation, Following Multi-Agency Trend

Client Alert

January 31, 2023
U.S. House of Representatives Establishes Select Committee on Strategic Competition with the Chinese Communist Party

Client Alert

January 11, 2023
House Republicans Establish New Select Subcommittees Focused on Pandemic and “Weaponization of the Federal Government”

Newsletter

June 28, 2022
Financial Services Focus – June 2022

Newsletter

June 27, 2022
Financial Services Focus - March 2022

Client Alert

July 2, 2020
Return to Work: Basics for "Non-Essential" Businesses

Client Alert

March 23, 2020
U.S. and EU Regulators and Institutions Issue Guidance on Clinical Trial Conduct during COVID-19 Pandemic

© 2025 King & Spalding LLP
  • Contact Us
  • Disclaimer
  • Privacy Notice
  • Transparency Disclosure
  • Cookie Policy
  • Copyright Notice
  • Regulatory Notices
  • Fraud Notice
  • Lawyers Alumni Group